Magazine Logo

David Gordon, MD — Distinguished Lifetime Achiever

Ann Arbor, MI — David Gordon, MD, is being recognized by Continental Who’s Who as a Distinguished Lifetime Achiever for his outstanding contributions as a Cardiovascular Pathologist, Medical Researcher, and Educator and in acknowledgment of his work with the University of Michigan.

A board-certified Cardiovascular Pathologist with more than 20 years of experience in his field, Dr. Gordon serves as the Director of Faculty Programs for the Office for Health, Equity, and Inclusion at the University of Michigan and as an Active Emeritus Professor of Pathology. He is additionally Dean Emeritus for the School of Health Professions and Studies at the University of Michigan-Flint.

In pursuit of his higher education, Dr. Gordon obtained a Bachelor of Arts in Chemistry at Amherst College and earned his Medical Degree from Harvard Medical School. While at Harvard, he completed a Vascular Biology Research Fellowship under Dr. Morris J. Karnovsky. He continued his extensive medical training with an Internal Medicine Internship at the University of Massachusetts in Worcester, MA, followed by an Anatomic Pathology Residency at the University of Washington in Seattle. At UW, Dr. Gordon also participated in post-doctoral medical research. Dr. Gordon is board certified by the American Board of Pathology and is a member of the Society for Cardiovascular Pathologists, among his professional affiliations.

Dr. Gordon began his teaching career on the faculty at the University of Washington as a human diagnostic and experimental cardiovascular pathologist. In 1991, he was recruited to the University of Michigan, where his focus has been on human atherosclerosis biology and gene therapy for vascular diseases.

He previously served as an Assistant Dean for Faculty Affairs for the University of Michigan Medical School. From 1997 to 2001, he was affiliated with Pfizer’s Cardiovascular Therapeutics, where his team of researchers conducted work on gene therapy for therapeutic angiogenesis. He returned to the University of Michigan full time in 2001 and became Dean of the School of Health Professions and Studies at the University of Michigan-Flint. In his current capacity as Director of Faculty Programs for the Office of Health Equity and Inclusion at the university, Dr. Gordon remains active in pathology instruction.

During his free time, he enjoys video game strategy, playing guitar, and singing.

Dr. Gordon would like to thank his dear wife, Zoe Koosis, for her love and support. He also wishes to lovingly acknowledge and remember his parents, the late William and Elizabeth Gordon. He dedicates this honorable recognition to his mentors, Dr. Morris J. Karnovsky, Dr. Steven Schwartz, Dr. Dennis Richenbach, and Dr. Stephen Betz.

About Author